---
category: trading
circular_id: 0ec17456b779a312
date: '2026-01-30'
description: 'BSE revokes the suspension of trading in equity shares of Citurgia Biochemicals
  Limited (Scrip Code: 506373), allowing resumption of trading activities.'
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={5B617286-D412-4441-940A-06F23BC76466}&noticeno=20260130-13&dt=01/30/2026&icount=13&totcount=21&flag=0
impact: high
impact_ranking: high
importance_ranking: high
justification: Revocation of trading suspension directly impacts investors' ability
  to trade shares and company's market liquidity
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260130-13&attachedId=88993662-c4db-4c37-b2b6-5642360eabf7
processing:
  attempts: 1
  content_hash: e90f60c91a438395
  processed_at: '2026-01-30T13:02:38.728716'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-30T09:51:51+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={5B617286-D412-4441-940A-06F23BC76466}&noticeno=20260130-13&dt=01/30/2026&icount=13&totcount=21&flag=0
severity: medium
source: bse
stocks:
- CITURGIA
tags:
- trading-suspension
- revocation
- equity-shares
- citurgia-biochemicals
- scrip-506373
title: Revocation of Suspension in Trading of Equity Shares of Citurgia Biochemicals
  Ltd.
---

## Summary

BSE has revoked the suspension in trading of equity shares of Citurgia Biochemicals Limited (Scrip Code: 506373, ISIN: INE795B01031). The company profile document provides comprehensive details about the company's operations, management, and compliance status as part of the revocation process.

## Key Points

- Trading suspension has been revoked for Citurgia Biochemicals Limited
- Scrip Code: 506373
- ISIN: INE795B01031
- Company engaged in manufacturing, processing, and dealing in citric acid
- Registered office located in Mumbai, Maharashtra
- Plant location at Virbhadra Road, Rishikesh, Uttarakhand
- Listed only on BSE Limited
- Current auditor: G.P. Keshri & Associates (appointed for FY 2022-2027)
- Company is in process of appointing a Company Secretary & Compliance Officer

## Company Leadership

**Managing Director & Chairman:** Mr. Kashi Nath Jha (DIN: 02072952)

**Board of Directors:**
- Mr. Vivek Singh
- Ms. Reena Devi Mandal
- Mr. Subhash Sahu
- Mr. Kashi Nath Jha
- Mr. Dharmendra
- Mr. Jitendra Prasad

## Compliance Requirements

- Company has paid listing fees to BSE
- No action taken by any other exchange in last five years
- Company maintains active operational status
- Auditor appointment valid through March 31, 2027
- Company Secretary & Compliance Officer position currently vacant and under recruitment

## Important Dates

- Document Date: November 7, 2025
- Circular Publication Date: January 30, 2026
- Auditor Term: April 1, 2022 to March 31, 2027

## Impact Assessment

**Market Impact:** High - The revocation of trading suspension restores market liquidity for shareholders and enables price discovery for the security. Investors who were unable to exit or enter positions during suspension can now trade freely.

**Operational Impact:** The company's ability to access capital markets is restored, improving its financial flexibility. The revocation indicates the company has addressed compliance issues or concerns that led to the original suspension.

**Compliance Status:** Company demonstrates compliance with listing requirements by maintaining updated disclosures, paying listing fees, and providing comprehensive company profile information. However, the absence of a Company Secretary & Compliance Officer is a gap that needs to be addressed.